Kiniksa Pharmaceuticals L...

22.41
-0.68 (-2.94%)
At close: Mar 31, 2025, 10:34 AM

Kiniksa Pharmaceuticals Ltd. Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -43.19M 14.08M 183.36M -157.92M -161.38M -161.87M -103.23M -64.87M -23.97M
Depreciation & Amortization 1.7M 2.34M 2.4M 2.35M 2.4M 2.07M 286K 28K 22K
Stock-Based Compensation 30.69M 27.15M 25.12M 25.17M 20.88M 15.08M 5.7M 897K 368K
Other Working Capital 46.81M 11.48M -2.01M 6.91M 654K -12.32M 9.51M 12.92M 1.64M
Other Non-Cash Items 3.55M 2.17M 2.99M 3.4M 1.52M 6.53M -1.12M -53K 293K
Deferred Income Tax 8.13M -33.79M -185.5M 11K 4.36M -3.16M -978K -197K -46K
Change in Working Capital 24.81M 1.35M -22.57M 689K -4.32M -17.02M 18.33M 13.93M 1.76M
Operating Cash Flow 25.69M 13.3M 5.81M -126.3M -136.53M -158.37M -81.01M -50.22M -21.87M
Capital Expenditures -277K -130K -105K -20.41M -283K -3.2M -5.29M -69K -3K
Acquisitions n/a n/a 91K 20M 23.16M -52.42M n/a n/a n/a
Purchase of Investments -202.01M -204.93M -135.86M -157.25M -430.21M -488.77M -402.01M n/a n/a
Sales Maturities Of Investments 239.94M 175.51M 127.8M 306.3M 407.05M 541.19M 168.1M n/a n/a
Other Investing Acitivies 25K n/a -7.97M -20M -23.16M 52.42M -233.91M n/a n/a
Investing Cash Flow 37.67M -29.56M -8.08M 128.63M -23.44M 49.21M -239.2M -69K -3K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased -4.98M -2.21M -901K 5.88M n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 17.25M 3.7M 3.42M 5.88M -1.14M 1M 187.54M 39.87M 42.51M
Financial Cash Flow 12.27M 1.5M 2.52M 5.88M 227.09M 84.11M 346.74M 39.87M 42.51M
Net Cash Flow 75.63M -14.76M 245K 8.22M 67.11M -25.05M 26.53M -10.41M 20.64M
Free Cash Flow 25.41M 13.17M 5.7M -146.71M -136.81M -161.57M -86.3M -50.29M -21.87M